University of Adelaide clinical trials
University of Adelaide is the lead sponsor of 4 current clinical trials in our Australia register. 2 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are N-Acetylcysteine. The most-studied condition is T2DM.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by University of Adelaide
4 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Effects of Calcium on Gut Functions and Blood Glucose in Humans With Type 2 Diabetes
NCT06942195 · ClinicalTrials.gov ↗ · T2DM
|
Not applicable | Recruiting | 2025-05 | Australia |
|
Effects of an Evening PROtein PrEload on Metabolic Health in Night ShIfT Workers (PROPENSITy)
NCT04869098 · ClinicalTrials.gov ↗ · Type 2 Diabetes, Shift-work Disorder
|
Not applicable | Recruiting | 2021-04 | Australia |
|
The Anti-Anginal Effects of N-Acetylcysteine (NAC) in Patients with Angina and Non-Obstructive Coronary Arteries (ANOCA)
NCT06890507 · ClinicalTrials.gov ↗ · Angina Attacks, Non Obstructive Coronary Artery Disease
Drug: N-Acetylcysteine |
Phase 2 | Not yet open | 2025-06 | Australia |
|
Effects of Combined Administration of Calcium and L-tryptophan on Gut Functions and Blood Glucose in Healthy Humans
NCT07013656 · ClinicalTrials.gov ↗ · Healthy
|
Not applicable | Not yet open | 2025-06 | Australia |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in University of Adelaide trials
1 compoundDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in University of Adelaide trials
6 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Australia | 4 | 2 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in T2DM
| Sponsor | Trials |
|---|---|
| Guangdong Raynovent Biotech | 2 |
| The First Affiliated Hospital of Henan University of Science and Technology | 1 |
Sponsors with the most current trials registered for this condition.
Questions about University of Adelaide trials
How many clinical trials does University of Adelaide sponsor?
University of Adelaide is the lead sponsor of 4 current trials on ClinicalTrials.gov in our Australia register, as of the registry sync on 14 November 2026. Completed and withdrawn studies are not counted.
Are University of Adelaide trials recruiting?
Yes. 2 of its 4 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is University of Adelaide testing?
Its current trials name 1 drug or biological as interventions. The most frequent are N-Acetylcysteine (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 14 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.